Keywords: switzerland, galderma, million, deal, acquire, collagenex, pharma
Switzerland's Galderma in $420 million deal to acquire CollaGenex Pharma
Article | 03 March 2008
Swiss dermatological pharmaceutical specialty group Galderma Pharma says it has entered into a definitive agreement to acquire Pennsylvania, USA-based CollaGenex, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
